Edition:
United Kingdom

ANI Pharmaceuticals Inc (ANIP.OQ)

ANIP.OQ on NASDAQ Stock Exchange Global Market

56.44USD
17 Oct 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$56.44
Open
$56.13
Day's High
$56.79
Day's Low
$55.43
Volume
19,264
Avg. Vol
31,071
52-wk High
$74.63
52-wk Low
$49.78

Chart for

About

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company focuses on areas, including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations.... (more)

Overall

Beta: 2.84
Market Cap(Mil.): $624.28
Shares Outstanding(Mil.): 11.64
Dividend: --
Yield (%): --

Financials

  ANIP.OQ Industry Sector
P/E (TTM): 119.03 85.92 33.73
EPS (TTM): 0.45 -- --
ROI: 1.72 0.63 14.31
ROE: 3.09 1.68 16.04

BRIEF-ANI Pharmaceuticals Reports Q1 GAAP Earnings Per Share $0.19

* ANI PHARMACEUTICALS REPORTS FIRST QUARTER 2018 RESULTS AND REAFFIRMS GUIDANCE

08 May 2018

BRIEF-Ani Pharmaceuticals To Acquire Generic Products And Assets From Amneal/Impax

* ANI PHARMACEUTICALS SIGNS DEFINITIVE AGREEMENTS TO ACQUIRE GENERIC PRODUCTS AND ASSETS FROM AMNEAL/IMPAX

27 Apr 2018

BRIEF-ANI Pharmaceuticals Announces Approval Of Morphine Sulfate Oral Solution

* ANI PHARMACEUTICALS ANNOUNCES APPROVAL OF MORPHINE SULFATE ORAL SOLUTION

18 Apr 2018

Earnings vs. Estimates